Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    0.00 (0.00%)
Bid:
18.70
Ask:
19.60
Spread: 0.90 (4.813%)
Market Cap: €108.24b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

"Dividend Option" execution timetable

12 Sep 2014 17:53

RNS Number : 5998R
Banco Bilbao Vizcaya Argentaria SA
12 September 2014
 



Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), in compliance with the Securities Market legislation, hereby proceeds by means of the present document to notify the following:

 

 

RELEVANT EVENT 

 

 

BBVA hereby communicates relevant information relating to the free-of-charge capital increase resolved by the General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented. Accompanying this relevant event notice is an information note related to the Dividend Option.

 

 

 

 

Madrid, 12th September 2014

INFORMATION NOTE

 

 

 

The General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, approved a free-of-charge capital increase for the instrumentation of the system of shareholder remuneration called "Dividend Option", which permits shareholders to elect to receive their remuneration in BBVA shares or, at their election, in cash.

 

The execution of such free-of-charge capital increase will be proposed for consideration by BBVA's Board of Directors, so that the Dividend Option may be implemented during October.

 

If BBVA's Board of Directors approves the execution of such free-of-charge capital increase in the terms and conditions of the proposal, it is expected to be executed in accordance with the following timetable:

 

· 24th September 2014: Communication of the number of rights necessary to receive one new share, and the definitive price at which BBVA has committed to purchase rights.

 

· 26th September 2014 (23:59 Madrid (Spain) time): Record date for allocation of rights.

 

· 29th September 2014: Rights trading period begins in Spain.

· 8th October 2014: Deadline for requesting payment in cash (sale of rights to BBVA).

 

· 13th October 2014: Rights trading period ends.

 

· 16th October 2014: Payment date to shareholders who have requested payout in cash (sale of rights to BBVA).

 

· 23rd October 2014: New shares allocated to shareholders.

 

· 24th October 2014: Initiation of ordinary trading of the new shares on the Spanish exchanges, subject to obtaining all necessary authorisations.

 

Finally, it is estimated that, assuming BBVA's Board of Directors approves the proposal for the execution of such free-of-charge capital increase, the approximate purchase price at which BBVA will purchase rights, in accordance with the formula approved by the General Meeting of BBVA shareholders, will be around 0.08 euros per right.

 

Madrid, 12th September 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMLVZZGDZM
Date   Source Headline
28th Dec 20173:26 pmRNSGMTN Programme Supplement to the Offering Circular
27th Dec 201712:59 pmRNSGMTN Programme - Issuer Substitution
27th Dec 201712:42 pmRNSGMTN Programme
21st Dec 20176:29 pmRNSPost Stabilisation Notice
15th Dec 20174:00 pmRNSPublication of approved ECP Information Memorandum
13th Dec 20175:35 pmRNSSREP Capital Requirements 2018
5th Dec 20177:22 amRNSTransmissions and purchases of capital undertaking
4th Dec 201710:47 amRNSFinal Terms 154SNP
29th Nov 20178:13 amRNSSale of real estate business
28th Nov 20177:00 amRNSBinding offer for the acquisition of BBVA Chile
24th Nov 20171:25 pmRNSFinal Terms 153SNP
10th Nov 201712:31 pmRNSFinal Terms Global Medium Term Note Programme
9th Nov 20177:00 amRNSAT1 Issuance for a total nominal amount
8th Nov 201710:52 amRNSPre Stabilisation Notice
7th Nov 20171:10 pmRNSOffer of securities contingently convertible
27th Oct 20174:29 pmRNSGMTN programme Supplement to the Offering Circular
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results press release
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results presentation
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results report
23rd Oct 20175:33 pmRNS3Q17 Results Presentation Announcement
6th Oct 201711:39 amRNSPost Stabilisation Notice BBVA EUR 5yr SNP
28th Sep 20177:55 amRNSHR News Real Estate
28th Sep 20177:00 amRNSDividend October 2017
4th Sep 20174:33 pmRNSFinal Terms 152 Execution version
31st Aug 20177:47 amRNSBBVA Chile News
30th Aug 20178:30 amRNSPre Stabilisation Notice BBVA 5yr EUR SNP
2nd Aug 20177:57 amRNSDBRS upgrades BBVA´s Cédulas Hipotecarias rating
1st Aug 201712:53 pmRNSFinal Supplement 2Q17
27th Jul 20176:04 pmRNS2Q17 Results Report
27th Jul 20175:46 pmRNS2Q17 Results Presentation
27th Jul 20175:30 pmRNS2Q17 Results Press Release
25th Jul 20175:39 pmRNSScope upgrades BBVA's senior unsecured rating
20th Jul 20175:18 pmRNSResults Presentation Announcement
12th Jun 20177:00 amRNSDBRS changes subordinated debt ratings
1st Jun 20177:00 amRNSBoard of Directors changes
25th May 201712:32 pmRNSFinal Terms GMTN151SUB
25th May 201711:26 amRNSFinal Terms
17th May 20177:00 amRNSAT1 Issuance
5th May 201712:55 pmRNSDividend Option
3rd May 201711:58 amRNSsupplemental to the Offering Circular
28th Apr 20178:43 amRNS2016 Audited Financial Statements
27th Apr 20177:00 amRNS1Q17 Results Report
27th Apr 20177:00 amRNS1Q17 Results Presentation
27th Apr 20177:00 amRNS1Q17 Press Release
24th Apr 20177:00 amRNSEnding trading period Dividend Option April 2017
21st Apr 20175:44 pmRNS1Q17 Results Presentation Announcement
12th Apr 20179:35 amRNSPost Stabilisation Notice
12th Apr 20179:24 amRNSPre Stabilisation Notice
5th Apr 20174:51 pmRNSFinal Terms GMTN Programme
3rd Apr 20179:31 amRNSPre Stabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.